關於優式創投

About UC VC

We build before the market
recognises the value
優式創投聚焦政策支持、產業趨勢與具成長潛力的企業,可投入資金逾百億元,不以短期資本利得為投資終點,可長期持有股份並與企業一同發展為目標。
自投資第一日起,即以邁進資本市場為目標,將企業成長所需的成功要素逐一拆解為不同專業模組,並逐項建立與跨域整合,協助創業團隊建立企業成功所需的關鍵能力,將技術與商業潛力轉化為可規模化的企業價值。
UC VC invests at the intersection of policy priorities, structural industry shifts, and long-term growth opportunities. With over NT$10 billion in deployable capital, we are built to invest beyond short-term returns. We can hold our positions for the long term and grow alongside the companies we back.
From day one, we work with founders toward the capital markets. We break down what it takes to build a successful company into distinct areas of expertise, then develop and connect them as the business grows. Our goal is to help teams build the capabilities they need to scale, turning strong technology and commercial potential into durable enterprise value.
提交投資計畫Submit Your Company

核心優勢 Why UC VC

Invest. Build. Scale.

01
優式創投不是單純的
財務投資者
More than a financial investor
我們希望解決的不只是「需要多少錢?」,而是「有了資本之後,企業如何快速成長?」不追求單一階段的投資回報,而是選擇與企業建立長期關係,即使進入資本市場,仍持續參與經營。

UC VC is not simply a financial investor.

The question is not just how much capital a company needs, but what it can build with that capital. We invest with a long-term view rather than optimizing for returns at a single stage. Our involvement does not necessarily end when a company enters the public markets. We aim to remain a long-term partner as the business continues to grow.

02
以市場為本的投資視角 A Market-Driven Perspective
優式創投具備市場研究背景,對企業的判斷不只停留在企業本身,更從市場角度理解企業所處的位置與未來價值。透過縱向與橫向比較,持續追蹤產業鏈、競爭對手、國際趨勢、前沿技術與市場估值,從更完整的市場視角判斷企業的競爭力與成長機會。

Our investment approach is grounded in market research. We evaluate a company not only on its own merits, but also in the context of the market around it.

We look both across and along the value chain, tracking competitors, global industry shifts, emerging technologies, and market valuations. This broader perspective helps us understand where a company stands today, what could change tomorrow, and where durable competitive advantage and growth can come from.

03
專業團隊各展所長 Expertise Where It Matters
在企業邁向資本化的同時,技術團隊得以專注於核心技術與產品發展。優式創投則將企業成長所需的經營要素模組化,依不同發展階段,導入產業、運營、財務、人才、科技、法務與品牌定位等專業資源,讓專業的人做專業的事。

As companies prepare for the capital markets, technical teams should be able to stay focused on what they do best: building technology and products.

UC VC organizes the capabilities required for growth into specialized modules. Depending on the company and its stage, we bring together expertise across industry, operations, finance, talent, technology, legal, and brand strategy. Each function is led by people who know the work, allowing founders and technical teams to stay focused on theirs.

04
優式創投不當小額投資人 Built to Invest at Scale
期待與經營團隊及產業專家深度合作,共同創造企業價值。依據企業不同發展與擴張階段,持續投入所需資本與專業資源,陪伴企業成長規模化過程中,資金不虞匱乏。

UC VC is not designed to be a small, passive shareholder.

We work closely with management teams and industry experts to build enterprise value together. As a company grows and its needs change, we can continue to provide the capital and expertise required at each stage. The goal is simple: companies should be able to scale without capital becoming the constraint.

投資焦點 Investment Focus

Investing in the Industries of Tomorrow

優式創投聚焦具備長期產業趨勢、
技術門檻與戰略發展機會的領域,

尋找能夠建立競爭壁壘,
並具備規模化與國際發展潛力的企業。

UC VC focuses on sectors shaped by long term industry trends, technological barriers and strategic growth opportunities. We look for companies with defensible competitive advantages and the potential to scale globally.

成功案例 Portfolio

Building the Next Stage of
Growth Together

  • 於 2026.8.31 興櫃 Listed on the Emerging Stock
    Market on August 31, 2026
    捷立康生技 (興櫃)
    A-TOP Health
    Taiwan Emerging Stock Market Company
    Website
    生醫材料與醫學美容科技,結合生物材料、人工智慧與電腦視覺等跨領域技術,發展新世代醫療器材與智慧醫療應用。透過自主研發與臨床需求整合,持續推動產品創新與技術平台發展,拓展醫療美容與生醫科技市場。
    A-TOP Health focuses on biomaterials and medical aesthetics, combining biomaterial science, artificial intelligence and computer vision to develop next generation medical devices and intelligent healthcare applications. Through in house R&D and close integration with clinical needs, the company continues to advance its technology platforms and expand across the medical aesthetics and biotechnology markets.
  • 凌霄航太 AerosoarX
    Website
    聚焦無人機與尖端科技,結合台灣製造與半導體供應鏈優勢,並運用 AI 技術強化無人系統的智慧化與整合能力。以自主研發、系統整合與關鍵技術為核心,積極布局海外市場,將台灣的科技與製造優勢延伸至全球無人機與軍用科技市場。

    Focused on drones and advanced technologies, we combine Taiwan’s strengths in manufacturing and semiconductor supply chains with AI to make autonomous systems more intelligent and integrated.

    We invest in companies with core capabilities in proprietary technology, system integration, and critical technologies, with the potential to compete globally. Our goal is to bring Taiwan’s technology and manufacturing strengths to the global drone and defense technology markets.

提交投資計畫 Submit Your Company

Your Vision
Deserves to be
Seen

如果你有能力解決需求痛點或提供新的技術應用,我們期待認識你。 If you are building a company with technological differentiation, industry advantages,
and strong growth potential, we want to hear from you.
提交投資計畫Submit Your Company
TOP